Red Journal Podcast April 1, 2025: Oligometastatic Head and Neck Cancer - Rationale for Upfront SABR

Dr. Sue Yom, Editor in Chief, co-hosts with Dr. Lachlan McDowell, Consultant Radiation Oncologist at the Princess Alexandra Hospital in Queensland, Australia and our journal's Head and Neck Cancer Section Editor. Guests are Dr. Sean McBride, Radiation Oncologist at Memorial Sloan Kettering Cancer Center and Chief of External Beam Radiotherapy at the Manhattan site, who authored an editorial, Oligometastatic HNSCC: Is SABR the Solution? , and Dr. Juliette Thariat, Professor in Radiation Oncology at Cancer Center Baclesse in Normandy, France, Secrétaire Nationale at the GORTEC, and first author of our featured article, Survival Without Quality of Life Deterioration in the GORTEC 2014-04 "OMET" Randomized Phase 2 Trial in Patients with Head and Neck Cancer with Oligometastases using Stereotactic Ablative Radiation Therapy (SABR) alone or Chemotherapy and SABR .

You can listen to Red Journal Podcast April 1, 2025: Oligometastatic Head and Neck Cancer - Rationale for Upfront SABR online on Radio and Podcast. Open the player on this page to stream the available audio.

Red Journal Podcast April 1, 2025: Oligometastatic Head and Neck Cancer - Rationale for Upfront SABR is an episode from ASTRO Journals by Elsevier.

This episode is 51:20 long.

This episode was published on Mar 13, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from ASTRO Journals when more episodes are available from the podcast feed.